kabutan

KOBAYASHI PHARMA, Jan-Mar (1Q) Ordinary Profit Decreases by 56%

Fri May 9, 2025 3:30 pm JST Earnings

4967 KOBAYASHI PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

KOBAYASHI PHARMACEUTICAL CO.,LTD. <4967> [TSE Prime] announced its financial results after the market closed on May 9th (15:30). The consolidated ordinary profit for the first quarter of the fiscal year ending December 2025 (January to March) significantly dropped 56.0% from the same period last year to 2.4 billion yen. The progress rate toward the full-year plan of 15.3 billion yen was 15.7%, almost the same as the five-year average of 18.8%.

In the most recent three-month period, from January to March (1Q), the operating profit margin significantly dropped from 13.8% in the same period last year to 7.8%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Mar, 2023 33,467 5,061 5,168 3,608 47.4 46.3 May 10, 2023 J-GAAP
Jan - Mar, 2024 36,485 5,028 5,461 976 13.1 52.3 May 10, 2024 J-GAAP
Jan - Mar, 2025 32,607 2,535 2,401 1,624 21.9 May 9, 2025 J-GAAP
YoY -10.6% -49.6% -56.0% +66.4% +66.5%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2024 73,136 9,471 10,434 1,436 19.3 43 Aug 8, 2024 J-GAAP
Jan - Jun, 2025 Guidance 44 Feb 10, 2025 J-GAAP
YoY

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 173,455 25,780 27,330 20,338 268.2 101 Feb 9, 2024 J-GAAP
Dec, 2024 165,600 24,860 26,861 10,067 135.4 102 Feb 10, 2025 J-GAAP
Dec, 2025 Guidance 171,000 14,000 15,300 10,500 141.3 104 Feb 10, 2025 J-GAAP
YoY +3.3% -43.7% -43.0% +4.3% +4.3%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 36,485 5,028 5,461 976 13.1 13.8 May 10, 2024 J-GAAP
Apr - Jun, 2024 36,651 4,443 4,973 460 6.2 12.1 Aug 8, 2024 J-GAAP
Jul - Sep, 2024 41,323 7,505 7,487 3,908 52.6 18.2 Nov 8, 2024 J-GAAP
Oct - Dec, 2024 51,141 7,884 8,940 4,723 63.5 15.4 Feb 10, 2025 J-GAAP
Jan - Mar, 2025 32,607 2,535 2,401 1,624 21.9 7.8 May 9, 2025 J-GAAP
YoY -10.6% -49.6% -56.0% +66.4% +66.5%

Related Articles